Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MDCO | The Medicines Co. | 0.33% | 84.18 | 20.1% | $581.82m | |
| AMRN | Amarin Corp. Plc | 0.41% | 21.90 | 1.7% | $313.14m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -0.43% | 28.83 | 14.1% | $169.64m | |
| BHC | Bausch Health Cos., Inc. | -0.43% | 28.83 | 0.0% | $100.83m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.98% | 149.55 | 2.3% | $100.37m | |
| GWPH | GW Pharmaceuticals Plc | -2.61% | 100.82 | 6.2% | $99.06m | |
| SAGE | SAGE Therapeutics, Inc. | 6.95% | 64.36 | 8.6% | $76.80m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -10.09% | 107.70 | 16.9% | $75.51m | |
| PRGO | Perrigo Co. Plc | 1.22% | 52.44 | 6.8% | $70.84m | |
| AXSM | Axsome Therapeutics, Inc. | 3.35% | 44.69 | 2.0% | $53.61m | |
| HZNP | Horizon Therapeutics Plc | 1.35% | 32.29 | 6.6% | $45.33m | |
| ICLR | ICON plc | 0.76% | 162.63 | 4.2% | $44.00m | |
| ENDP | Endo International Plc | 0.73% | 4.86 | 8.8% | $35.24m | |
| UTHR | United Therapeutics Corp. | 1.66% | 91.73 | 14.3% | $34.04m | |
| MYOK | MyoKardia, Inc. | 0.55% | 67.49 | 2.1% | $30.17m |
Company Profile
MEI Pharma, Inc. engages in the clinical development of therapies for cancer. Its drug candidates includes Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Its pipeline also consists of ME-401, an oral PI3K delta inhibitor; Voruciclib, an oral CDK inhibitor; and ME-344, a mitochondrial inhibitor. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.